Myeloproliferative neoplasms: open trials in Japan

11 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Kobe
Registry updated 2026-11-09
NCT07357727
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Bunkyo Ku · Chūō · Fukuoka · Kamogawa · Kobe · Kumamoto · Kurashiki · Miyazaki · Sapporo · Shiwa-Gun · Toyoake · Tsu
Registry updated 2026-11-06
NCT07623161
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Trial Treatment · Phase 3 · Takeda
Tokyo Metropolitan Komagome Hospital, Bunkyo Ku · Chiba Cancer Center, Chiba · University of Yamanashi Hospital, Chuo-shi · Hitachi General Hospital, Hitachi · Kobe City Medical Center General Hospital, Kobe · University of Miyazaki Hospital, Miyazaki · Ehime University Hospital, Toon-shi · Mie University Hospital, Tsu
Registry updated 2026-11-06
NCT07623200
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Trial Treatment · Phase 3 · Incyte Corporation
Nippon Medical School Hospital, Bunkyō City · Juntendo University Hospital, Bunkyō City · University of Yamanashi Hospital, Chūō · Kyushu University Hospital, Fukuoka · Fukushima Medical University Hospital, Fukushima · Kansai Medical University Hospital, Hirakata · Kagoshima University Hospital, Kagoshima · National Cancer Center Hospital East, Kashiwa-shi · Kobe City Medical Center General Hospital, Kobe · University of Miyazaki Hospital, Miyazaki · Osaka Metropolitan University Hospital, Osaka · Kindai University Hospital, Sakai · Tokyo Medical University Hospital, Shinjuku-ku · Ehime University Hospital, Tōon · Mie University Graduate School of Medicine, Tsu
Registry updated 2026-11-05
NCT06150157
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Juntendo University Hospital, Bunkyō City · National Cancer Center Hospital East, Kashiwa
Registry updated 2026-11-04
NCT07441694
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Trial Treatment · Phase 1 · Incyte Corporation
National Cancer Center Hospital East, Kashiwa, Chiba · Ehime University Hospital, Toon, Ehime
Registry updated 2026-10-30
NCT07429266
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Trial Treatment · Phase 3 · Ono Pharmaceutical Co., Ltd.
Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki · Osaka Metropolitan University Hospital, Osaka · Tokyo Women's Medical University Hospital, Tokyo · Institute of Science Tokyo Hospital, Tokyo
Registry updated 2026-10-29
NCT04176198
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
Aichi Medical University Hospital, Aichi · Aomori Prefectural Central Hospital, Aomori · National Cancer Center Hospital East, Chiba · Kyushu University Hospital, Fukuoka · Hokkaido University Hospital, Hokkaido · Shonan Kamakura General Hospital, Kamakura · University of Miyazaki Hospital, Miyazaki · Okayama University Hospital, Okayama · The University of Osaka Hospital, Osaka · Saitama Medical Center, Saitama · Tohoku University Hospital, Sendai · Shizuoka Cancer Center, Shizuoka · Tokyo Medical University Hospital, Tokyo · Nerima Hikarigaoka Hospital, Tokyo · Juntendo University Hospital, Tokyo · Mie University Hospital, Tsu
Registry updated 2026-10-02
NCT07648030
A Study of Rusfertide in Japanese Adults With Polycythemia Vera
Trial Treatment · Phase 2 · Takeda
Juntendo University Hospital, Bunkyo-ku · University of Yamanashi Hospital, Chūō · Gunma University Hospital, Maebashi · University of Miyazaki Hospital, Miyazaki · Nagoya Medical Center, Nagoya · Tokyo Medical University Hospital, Shinjuku-ku · University of Osaka Hospital, Suita · Tokyo Metropilitan Bokutoh Hospital, Sumida-ku · Mie University Hospital, Tsu
Registry updated 2026-10-02
NCT04064060
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Trial Treatment · Phase 3 · Celgene
Chiba · Japanese Red Cross Society Himeji Hospital, Himeji · Hitachi · Shonan Kamakura General Hospital, Kamakura · Kamogawa · Matsuyama Red Cross Hospital, Matsuyama · Nagasaki · Nagoya · Ogaki Municipal Hospital, Ōgaki · Osaka · Sagamihara · Sakai · Sendai · Sendai · Shibuya City · NTT Medical Center Tokyo, Shinagawa City
Registry updated 2026-07-01
NCT04655092
Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
Trial Treatment · Phase 3 · PharmaEssentia Japan K.K.
Juntendo University Hospital, Bunkyo-ku · University of Yamanashi Hospital, Chuo-shi · Tokyo Medical University Hospital, Shinjuku-ku · Osaka University Hospital, Suita-shi · Ehime University Hospital, Toon-shi · Mie University Hospital, Tsu
Registry updated 2024-11-08

All Myeloproliferative neoplasms trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error